Skip to content

Uncontrolled Donation After Circulatory Determination of Death (uDCDD)

Uncontrolled Donation After Circulatory Determination of Death (uDCDD): A Potential Solution to the Shortage of Organs in Quebec?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03935230
Acronym
uDCDD
Enrollment
1111
Registered
2019-05-02
Start date
2016-05-31
Completion date
2016-08-31
Last updated
2019-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uncontrolled Donation After Circulatory Determination of Death

Keywords

unexpected cardiopulmonary arrest, potential organ donors

Brief summary

World-wide, patients waiting for organ transplantation exceed the number of organs available. Many European countries have a uDCDD program which contribute to 10-15% of the donor pool. In Canada, this type of program does not exist. The purpose of this study is to report how many deceased person fulfill the criteria for uncontrolled DCDD in a Canadian medical center.

Detailed description

While transplantation has become the definitive treatment for many people suffering end-stage organ failure, demand exceeds supply. For many years, donation after neurological death represented the principal source of organs for transplantation. In the last decade, prevention measures, improvements in neurocritical care, and decompressive craniectomy have led to a significant decrease in the number of non-directed donors (NDDs). In such situations, alternative sources for organ donation must be identified. Cardiac-arrest patients could provide a solution to this organ shortage. Patients who have experienced unexpected in or out of hospital cardiopulmonary arrest could become organ donors. Organ donation following uncontrolled cardiocirculatory death is currently practiced in many European countries. However, in Canada, it's not yet authorized. Yet, each deceased could save up to four lives. The purpose of this study is to determine the organ potential for a cohort of patient who had died from a cardiopulmonary arrest at the CHUS in 2015 and assess the effect of the implementation of a uDCD program on the number of additional donors.

Interventions

None listed

Sponsors

Université de Sherbrooke
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* All patients treated for cardiocirculatory arrest at the CIUSSS-Estrie CHUS in 2015.

Exclusion criteria

* Patients with a status of no resuscitation * Pediatric patients (\<18 years old) * Adults \>65 years old

Design outcomes

Primary

MeasureTime frameDescription
Potential contribution of a uDCDD program on the number of additional donors.1 yearDefined as (must meet all criteria): * Age ≤70 years old * Absence of obvious cause of death (rigor mortis, decapitation, overwhelming traumatic injury) * Absence of surgical cause of cardiac arrest * No sign of IV drug abuse * No history of malignancies

Secondary

MeasureTime frameDescription
Effect of the implementation of a uDCDD program on the number of additional organs suitable for transplantation.1 yearEffect of the implementation of a uDCDD program on the number of additional organs suitable for transplantation.
Number of tissus donors1 yearNumber of tissus donors
Potential obstacles and solutions related to the implementation of a uDCDD program in Canada.1 yearPotential obstacles and solutions related to the implementation of a uDCDD program in Canada.
Areas of future research.1 yearAreas of future research.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026